跳至主要内容
临床试验/KCT0000761
KCT0000761尚未招募未知

Comparative study of intravenous ketorolac tromethamine and insertion of pancreatic duct stent to prevent post-ERCP pancreatitis : pilot study

Hallym University Medical Center-Kangnam0 个研究点目标入组 360 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
360

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
19(Year) 至 75(Year)(—)
性别
All

入选标准

  • patient with disease for which endoscopic retrograde cholangiopancreatogram is indicated for diagnosis or treatment

排除标准

  • 1) Unwillingness or inability to consent for the study
  • 2) Age < 18 years or age=18 years or age >75 years
  • 3) Intrauterine pregnancy
  • 4) Breast feeding mother
  • 5) Standard contraindications to ERCP
  • 6) Allergy to Aspirin or NSAIDs
  • 7) Renal failure (Cr > 1.4)
  • 8) Active or recent (within 4 weeks) gastrointestinal hemorrhage
  • 9) Existing acute pancreatitis within 72 hours prior to ERCP
  • 10) Known chronic calcific pancreatitis
  • 11) Pancreatic head malignancy
  • 12) congenital anomaly of pancreatobiliary system
  • 13) ERCP for biliary stent removal or exchange
  • 14) Subjects with prior biliary sphincterotomy

研究者

发起方
Hallym University Medical Center-Kangnam

相似试验